|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsim NC, Frampton AE, Habib NA and Jiao
LR: Surgical treatment for liver cancer. World J Gastroenterol.
16:927–933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guégan JP, Ezan F, Théret N, Langouët S
and Baffet G: MAPK signaling in cisplatin-induced death:
predominant role of ERK1 over ERK2 in human hepatocellular
carcinoma cells. Carcinogenesis. 34:38–47. 2013. View Article : Google Scholar
|
|
4
|
Tsao CM, Yan MD, Shih YL, et al: SOX1
functions as a tumor suppressor by antagonizing the WNT/β-catenin
signaling pathway in hepatocellular carcinoma. Hepatology.
56:2277–2287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q and
Cao P: Evodiamine inhibits STAT3 signaling by inducing phosphatase
shatterproof 1 in hepatocellular carcinoma cells. Cancer Lett.
328:243–251. 2013. View Article : Google Scholar
|
|
6
|
Yang P, Li QJ, Feng Y, et al:
TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment
promotes venous metastases of HBV-positive hepatocellular
carcinoma. Cancer Cell. 22:291–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Agnihotri G and Liu HW: Enoyl-CoA
hydratase reaction, mechanism, and inhibition. Bioorg Med Chem.
11:9–20. 2003. View Article : Google Scholar
|
|
8
|
Lin JF, Xu J, Tian HY, et al:
Identification of candidate prostate cancer biomarkers in prostate
needle biopsy specimens using proteomic analysis. Int J Cancer.
121:2596–2605. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Komori T, Takemasa I, Higuchi H, et al:
Identification of differentially expressed genes involved in
colorectal carcinogenesis using a cDNA microarray. J Exp Clin
Cancer Res. 23:521–527. 2004.PubMed/NCBI
|
|
10
|
Yeh CS, Wang JY, Cheng TL, Juan CH, Wu CH
and Lin SR: Fatty acid metabolism pathway play an important role in
carcinogenesis of human colorectal cancers by
Microarray-Bioinformatics analysis. Cancer Lett. 233:297–308. 2006.
View Article : Google Scholar
|
|
11
|
Liu X, Feng R and Du L: The role of
enoyl-CoA hydratase short chain 1 and peroxiredoxin 3 in
PP2-induced apoptosis in human breast cancer MCF-7 cells. FEBS
Lett. 584:3185–3192. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang Y, Wang SX, Wang YB, et al: ECHS1
interacts with STAT3 and negatively regulates STAT3 signaling. FEBS
Lett. 587:607–613. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiao CX, Yang XN, Huang QW, et al: ECHS1
acts as a novel HBsAg-binding protein enhancing apoptosis through
the mitochondrial pathway in HepG2 cells. Cancer Lett. 330:67–73.
2013. View Article : Google Scholar
|
|
14
|
Kira S, Nakanishi T, Suemori S, Kitamoto
M, Watanabe Y and Kajiyama G: Expression of transforming growth
factor alpha and epidermal growth factor receptor in human
hepatocellular carcinoma. Liver. 17:177–182. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ito Y, Takeda T, Sakon M, et al:
Expression and clinical significance of erb-B receptor family in
hepatocellular carcinoma. Br J Cancer. 84:1377–1383. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prigent SA and Lemoine NR: The type 1
(EGFR-related) family of growth factor receptors and their ligands.
Prog Growth Factor Res. 4:1–24. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barnard JA, Beauchamp RD, Russell WE,
Dubois RN and Coffey RJ: Epidermal growth factor-related peptides
and their relevance to gastrointestinal pathophysiology.
Gastroenterology. 108:564–580. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
DeCicco LA, Kong J and Ringer DP:
Carcinogen-induced alteration in liver epidermal growth factor
receptor distribution during the promotion stage of
hepatocarcinogenesis in rat. Cancer Lett. 111:149–156. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Whittaker S, Marais R and Zhu AX: The role
of signaling pathways in the development and treatment of
hepatocellular carcinoma. Oncogene. 29:4989–5005. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jazag A, Ijichi H, Kanai F, et al: Smad4
silencing in pancreatic cancer cell lines using stable RNA
interference and gene expression profiles induced by transforming
growth factor-beta. Oncogene. 24:662–671. 2005. View Article : Google Scholar
|
|
22
|
Guleng B, Tateishi K, Ohta M, et al:
Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates
in vivo tumor growth by inhibiting angiogenesis in a vascular
endothelial growth factor-independent manner. Cancer Res.
65:5864–5871. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu XS, Dai YC, Chen ZX, Xie JP, Zeng W,
Lin YY and Tan QH: Knockdown of ECHS1 protein expression inhibits
hepatocellular carcinoma cell proliferation via suppression of Akt
activity. Crit Rev Eukaryot Gene Expr. 23:275–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kelman Z and O’Donnell M: Structural and
functional similarities of prokaryotic and eukaryotic DNA
polymerase sliding clamps. Nucleic Acids Res. 23:3613–3620. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Carpenter G: Receptors for epidermal
growth factor and other polypeptide mitogens. Annu Rev Biochem.
56:881–914. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schlessinger J: Cell signaling by receptor
tyrosine kinases. Cell. 103:211–225. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yarden Y and Sliwkowski MX: Untangling the
ErbB signalling network. Nat Rev Mol Cell Biol. 2:127–137. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Soltoff SP, Carraway KR III, Prigent SA,
Gullick WG and Cantley LC: ErbB3 is involved in activation of
phosphatidylinositol 3-kinase by epidermal growth factor. Mol Cell
Biol. 14:3550–3558. 1994.PubMed/NCBI
|
|
31
|
Schmitz KJ, Wohlschlaeger J, Lang H, et
al: Activation of the ERK and AKT signalling pathway predicts poor
prognosis in hepatocellular carcinoma and ERK activation in cancer
tissue is associated with hepatitis C virus infection. J Hepatol.
48:83–90. 2008. View Article : Google Scholar
|
|
32
|
Saxena NK, Sharma D, Ding X, Lin S, Marra
F, Merlin D and Anania FA: Concomitant activation of the JAK/STAT,
PI3K/AKT, and ERK signaling is involved in leptin-mediated
promotion of invasion and migration of hepatocellular carcinoma
cells. Cancer Res. 67:2497–2507. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Steelman LS, Chappell WH, Abrams SL, et
al: Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in
controlling growth and sensitivity to therapy-implications for
cancer and aging. Aging (Albany NY). 3:192–222. 2011.
|
|
34
|
Bill HM, Knudsen B, Moores SL, Muthuswamy
SK, Rao VR, Brugge JS and Miranti CK: Epidermal growth factor
receptor-dependent regulation of integrin-mediated signaling and
cell cycle entry in epithelial cells. Mol Cell Biol. 24:8586–8599.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lui VW and Grandis JR: EGFR-mediated cell
cycle regulation. Anticancer Res. 22:1–11. 2002.PubMed/NCBI
|
|
36
|
Horn S, Endl E, Fehse B, Weck MM, Mayr GW
and Jücker M: Restoration of SHIP activity in a human leukemia cell
line downregulates constitutively activated phosphatidylinositol
3-kinase/Akt/GSK-3beta signaling and leads to an increased transit
time through the G1 phase of the cell cycle. Leukemia.
18:1839–1849. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Diehl JA, Cheng M, Roussel MF and Sherr
CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis
and subcellular localization. Genes Dev. 12:3499–3511. 1998.
View Article : Google Scholar : PubMed/NCBI
|
